Patent assignee · US · COMPANY

Nexgenix Pharmaceuticals, Inc.

3Patents
3Active
3Granted
41Portfolio score

Filing activity: Feb 2, 2006 → Jun 15, 2012 · 2 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8487004B2 Local treatment of neurofibromas Human Necessities 6 Active
US8211875B2 Local treatment of neurofibromas Human Necessities 1 Active
US8329683B2 Treatment of neurofibromatosis with radicicol and its derivatives Human Necessities 1 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.